(and dosage form):
Each tablet contains
|| 100 mg|
|| 200 mg|
|| 200 micrograms|
A.22.1.4 - Vitamins: Others
NEUROBION tablets are indicated where a deficiency of the relevant vitamins exists.
NEUROBION should not be used in patients on Levodopa therapy.
Hypersensitivity to any of the above ingredients.
DOSAGE AND DIRECTIONS FOR USE:
NEUROBION tablets may be administered in a dosage of 1 daily.
SIDE-EFFECTS AND SPECIAL PRECAUTIONS:
Cyanocobalamin should not be given before a diagnosis has been fully established because of the possibility of masking symptoms of subacute degeneration of the spinal cord.
Cyanocobalamin is not a suitable form of Vitamin B12 for the treatment of optic neuropathies associated with raised plasma concentrations of cyanocobalamin.
KNOWN SYMPTOMS OF OVERDOSAGE AND PARTICULARS OF ITS TREATMENT:
Treatment is symptomatic and supportive.
White, shiny, round coated tablets, steeply convexed on both sides.
Clear glass bottle containing 10 tablets.
Amber glass bottle containing 100 tablets.
Store below 25°C
KEEP OUT OF REACH OF CHILDREN.
H2487 (Act 101/1965).
NAME AND BUSINESS ADDRESS OF THE APPLICANT:
Merck (Pty) Ltd.
Reg. No. 1970/04059/07
1 Friesland Drive
Longmeadow Business Estate
DATE OF PUBLICATION OF THIS PACKAGE INSERT:
11 March 1988
® = Registered Trade Mark
Updated on this site: November 2004
Source: Community Pharmacy
SAEPI HOME PAGE
TRADE NAME INDEX
GENERIC NAME INDEX
Information presented by Malahyde Information Systems © Copyright 1996-2004